Amgen Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Amgen Inc. (AMGN) holds an ST Score of 55.7 out of 100 (B-), with its strongest factor being Sentiment (A) and its weakest Valuation (D). Analysts rate AMGN Buy across 41 ratings with a $393.72 average price target (+0.0% vs the current $393.16).
- Strongest
- SentimentA
- Weakest
- ValuationD
All factor grades
- SentimentA
- ProfitabilityA-
- GrowthB
- MomentumB-
- ForecastC-
- Financial StrengthD+
- ValuationD
- Piotroski8/9
Contact
AMGN stock: frequently asked questions
What is AMGN's ST Score?
Amgen Inc. (AMGN) has an ST Score of 55.7 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AMGN a buy, sell, or hold?
Wall Street's consensus rating on AMGN is Buy based on 41 analyst ratings. Our own ST Score grades it B- (55.7/100). This is data, not investment advice — always do your own research.
What is AMGN's valuation grade?
Amgen Inc. (AMGN) earns a valuation grade of D, measured against Drug Manufacturers - General peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AMGN's growth grade?
Amgen Inc. (AMGN) earns a growth grade of B, measured against Drug Manufacturers - General peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AMGN's profitability grade?
Amgen Inc. (AMGN) earns a profitability grade of A-, measured against Drug Manufacturers - General peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AMGN's financial strength grade?
Amgen Inc. (AMGN) earns a financial strength grade of D+, measured against Drug Manufacturers - General peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AMGN?
The average analyst price target for Amgen Inc. (AMGN) is $393.72 from 41 analysts, which is +0.0% versus the recent price of $393.16.
What is AMGN's Piotroski score?
Amgen Inc. (AMGN) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.